Cadence vs Verily Health (2026)
Two supervised agent models for chronic care, sold to different buyers. Cadence partners with health systems and runs chronic care management for older adults at home, monitoring daily vitals for hypertension, diabetes, heart failure and lung disease; its home page says 99 percent of alerts are resolved without physician escalation, and a peer reviewed multi site study stands behind its cost and utilization claim. Verily Health sells to health plans, employers and pharmacy benefit managers, with agents triaging and escalating members to a clinical team, ISO 27001 certification named, and records retrieved only after a member consents to care. The split is contractual rather than technical. If the buyer is a provider organization billing chronic care management, Cadence. If it is a plan or employer managing a metabolic population, Verily Health.
- It states how its supervised agents are used: 99 percent of alerts resolved without physician escalation and care team calls answered within five minutes.
- A peer reviewed, multi site study in Mayo Clinic Proceedings with a comparison group stands behind its cost and utilization claim, alongside a publication record cited on its own site.
- The population and conditions are enumerated rather than described: older adults at home with hypertension, type 2 diabetes, heart failure and chronic obstructive pulmonary disease.
- The escalation design is the product rather than a fallback, with agents triaging and escalating members to a clinical team, and the commitments are published in language a member can actually read.
- Records are gathered by its affiliated provider group only after a member consents to care, with member facing commitments on consent, use limitation and encryption, and ISO 27001 certification named on a trust page.
- Retrieval breadth is real and honestly bounded, with the affiliated clinical entity gathering records with member consent and the limits of that stated rather than glossed.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Cadence and Verily Health are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Cadence | Verily Health |
|---|---|---|
| Primary category | Remote Monitoring & Chronic Care | Remote Monitoring & Chronic Care |
| Founded | Not recorded | 2015 |
| Headquarters | New York, New York | South San Francisco, California |
| Website | cadence.care | verily.com |
Side by Side
Select any grade to read the note behind it.
Product updates
The latest logged changes from each vendor, newest first, each linked to its source.
Cadence
-
Clinical evidence
Cadence reported an interim result from Hackensack Meridian Health, where more than 6,000 patients are managed at home with connected devices and a Cadence clinical team working under the health system's own protocols.
Source -
Regulatory / FDA
Cadence announced that its HypertensionOS software was selected by the FDA as the second participant in the TEMPO for Digital Health Devices Pilot.
Source
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
AI enabled chronic care management for older adults, run in partnership with health systems: AI agents monitor daily vitals from connected devices in patients' homes and handle medication titration, lifestyle coaching, alert triage, care coordination and symptom assessment, working with an embedded clinical team for patients with hypertension, type 2 diabetes, heart failure and COPD. The company reports more than 20 partner health systems, 99 percent of alerts resolved without physician escalation and care team calls answered within five minutes.
Source: AI Health Index, September 2026
Precision health company, renamed Verily Health in April 2026 when it became independent of Alphabet (Alphabet remains a significant minority investor after a $300 million round led by Series X Capital).
Source: AI Health Index, September 2026
Questions buyers ask
How do Cadence and Verily Health work with the EHR?
Cadence clinical staff work inside partner health system workflows and the company describes deep record system integration, and the home page names partner health systems (Montefiore Einstein, Providence, Duke Health, Yale New Haven Health, Rush, Sharp and UC Health among more than 20).
With Verily Health, the company names Syntax, its model, as FHIR native. The exchanges and health systems are not named, and nothing describes a return path: whether care team notes, escalations or outcomes reach the member's own physician or record. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 28, 2026. No vendor pays for placement.
How do Cadence and Verily Health handle patient data?
In Cadence's case, three data streams need answers: daily readings from connected devices in patients' homes, which accumulate over years in a chronic care program; text and phone conversations between patients and automated agents, including any call audio; and clinical staff access to partner health system records.
The Lightpath privacy policy, issued by Verily Health Inc., may set out retention and training terms. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 28, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers.
Both wrap software around a clinical service, so a buyer is purchasing labor as well as models and should price it that way. Cadence publishes no security attestation, retention position, training use statement or hosting detail, and its deep record system integration is claimed without naming the systems. Verily Health names its products and agents but not the technology beneath them, and publishes no governance framework or model documentation.
Neither publishes subgroup performance, which matters in remote monitoring because device adherence and connectivity vary sharply with income, age and housing, and a patient whose readings stop arriving looks identical to a patient who is well.